CloudHealth Technologies Expands Business in Europe
CloudHealth Technologies, the leader in cloud service management, today announced that it is expanding its customer base, partner list and business operations in the European region. Helping to fuel the expansion is $46 million in Series D funding, which the company secured in June. The funding round will help CloudHealth Technologies scale international operations and double the size of its global workforce.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170720005189/en/
CloudHealth Technologies Expands Business in Europe (Photo: Business Wire)
Cloud adoption in EMEA is growing steadily, with the market projected to reach €44.8 billion by the year 2020, according to Market Research & Statistics1. As enterprises turn to the cloud to build apps and manage operations, they improve productivity but, at the same time, face challenges dealing with cloud complexity and managing cost.
“It comes as no surprise that public cloud adoption is accelerating in the European market, given its reputation as a hotbed for technology innovation” said Larry Begley, CFO of CloudHealth Technologies. “Enterprises in the UK and across EMEA are using CloudHealth for visibility into their cloud resources. This allows them to cut costs, improve performance, manage risks, migrate workloads and set policies. Over the next few years, our local presence will continue to grow in order to support our global customers and partners.”
In the past twelve months, CloudHealth Technologies has grown its number of direct customers in EMEA by 72 percent. During that same period, the number of partners for the region increased by 500 percent. To support this continued growth, CloudHealth Technologies has opened offices in Amsterdam and in Tel Aviv, where it counts three of the top Israeli service providers as partners: CloudZone, DoIT and AllCloud. The company also moved to an expanded office in central London, with a local workforce that will look to double by year-end 2017.
In-region event participation will continue to be a focus. Earlier this year, local cloud leaders gathered together for a CloudHealth Connect community event in London to discuss cloud challenges and best practices related to cost management, scale, security and governance. CloudHealth Technologies also exhibited at AWS Summits in London and Tel Aviv, and participated in the Cape Town Summit with partner First Distribution. During these events, booth visitors learned about the latest platform enhancements and met with cloud management experts.
“The cloud is an incredible business enabler, but scaling it can be a challenge without proper visibility,” said Tyrone Forbes, Senior Capacity and Performance Manager, EE. “When we looked for a way to optimize our AWS environment, CloudHealth was the obvious choice. It helps us control cost and usage, as well as manage thousands of EC2 instances.”
“We’re seeing huge interest in strategic cloud services, and our mission is to help others sell these services as quickly as possible,” said Russell Warne, AWS Lead at First Distribution, a CloudHealth Technologies partner based in South Africa. “CloudHealth is simply one of the strongest levers we offer. Even a new entrant can start adding significant value to customers in an incredibly short space of time.”
CloudHealth Technologies’ list of EMEA customers includes EE, Elastera, Financial Times, Funding Circle, Telefonica, Transport for London and Randstad. CloudHealth has also added many EMEA service providers to its growing Cloud Business Accelerator Program. New partners include ACA IT-Solutions, AllCloud, ANS Group, CDW, DoIT, HeleCloud, PA Consulting, Rebura LTD, Sopra Steria, Softcat plc, Storm Reply and Taldor Cloud market.
To learn more, visit www.cloudhealthtech.com.
- Blog: Financial Times: Gamifying Cost Optimization with CloudHealth
- Case study: The Economist’s Big Move to the Cloud with Help from Cloudreach and CloudHealth
- Video: NewCloudViews -- Elastera
- Video: NewCloudViews -- Cloudreach
About CloudHealth Technologies
CloudHealth, the recognized worldwide leader in the growing Cloud Service Management industry, provides integrated reporting, recommendations and active policy management to help companies control the problems associated with “cloud chaos.” Our comprehensive platform gives enterprise companies and MSPs the ability to visualize, optimize and govern their cloud and hybrid environments. By providing analysis and deep insight into historical trends, capacity planning, resource optimization and resource automation, CloudHealth enables stakeholders ranging from C-level executives to engineers, cloud specialists, architects, IT directors and LOB managers to improve performance and drive value through their cloud ecosystems. Well-known organizations that rely on CloudHealth’s capabilities and expertise include Amtrak, Dow Jones, Acquia, and Sumo Logic, among others. Based in Boston, the company is backed by Kleiner Perkins, Meritech Capital Partners, Sapphire Ventures, Scale Venture Partners, .406 Ventures and Sigma Prime Ventures. For continuous product updates, industry news and engagement visit us at www.cloudhealthtech.com or follow us @cloudhealthtech.
1 Telecom News, April 24, 2017.
Mike O’Connell or Lisa Sorrentino, 617-502-4300
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Timor Telecom Enhances International Voice Connections in Timor-Leste Through SES Networks18.12.2017 07:55 | Pressemelding
Timor Telecom (TT), the largest telecommunications operator in Timor-Leste, has expanded its partnership with SES Networks to enable international voice traffic between Timor-Leste and the rest of the world, SES announced today. Under the new agreement, TT will contract capacity on the high-powered NSS-12 geostationary earth orbit (GEO) satellite to establish a point-to-point link connecting Dili, Timor with Sintra, Portugal. Today, residents of Timor-Leste benefit from high speed 4G/LTE mobile data and broadband services provided by TT, which are powered by SES’s O3b medium earth orbit (MEO) satellite network. With its capacity uptake on NSS-12, TT will broaden its suite of services with the carriage of international voice traffic between Timor-Leste and the rest of the world. This enables TT to continue empowering local communities with superior services and to meet all th
Steeper Energy Announces EUR 50.6 M (DKK 377 M) Advanced Biofuel Project with Norwegian-Swedish joint venture Silva Green Fuel in Licensing Deal18.12.2017 07:00 | Pressemelding
Steeper Energy, a Danish-Canadian clean-fuel company, is partnering with Silva Green Fuel, a Norwegian-Swedish joint venture, to construct a EUR 50.6 M (DKK 377M) industrial scale demonstration plant at a former pulp mill located in Tofte, Norway leading to a future commercial scale project. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171217005029/en/ Steeper will license its proprietary Hydrofaction™ technology to Silva, who will build the facility over the next 18 months. The demonstration plant will use woody residues as feedstock that are converted to renewable crude oil and, in turn, will be upgraded to renewable diesel, jet or marine fuel. Steeper’s Hydrofaction™ technology was selected by Silva after an exhaustive due diligence review of some 40 other technologies. Hydrofaction™ harnesses water
Yokogawa Develops N-IO Standard Field Enclosure and Control System Virtualization Platform18.12.2017 02:00 | Pressemelding
Yokogawa Electric Corporation (TOKYO:6841) announces that it has developed an N-IO standard field enclosure and a control system virtualization platform. The enclosure is a weatherproof remote IO cabinet that stores IO devices used by the CENTUM(R) VP integrated production control system and the ProSafe(R)-RS safety instrumented system, and the virtualization platform enables the control of multiple virtual devices on a single server. By reducing the amount of time and effort to engineer a new system, these solutions help to both speed up project execution and reduce total cost of ownership (TCO). The N-IO standard field enclosure is scheduled to be released in February 2018, and the virtualization platform will be released in May 2018. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171217005010/en/ N-I
Celltrion Receives Positive CHMP Opinion for Herzuma® for Trastuzumab Biosimilar15.12.2017 22:13 | Pressemelding
Celltrion, Inc. (KOSDAQ: 068270) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending that Herzuma® (trastuzumab biosimilar) be granted marketing authorization in the European Union (EU) for the treatment of patients with early breast cancer, metastatic breast cancer, or metastatic gastric cancer whose tumors have either HER2 overexpression or HER2 gene amplification. The CHMP’s opinion will now be sent to the European Commission (EC) for final review. Herzuma® is a biosimilar to Herceptin®i, a breast cancer and gastric cancer treatment antibody biologic drug developed by Genentech and marketed by Roche. Herceptin® is a blockbuster drug which had worldwide sales of CHF 6.8 billionii (US$6.8 billion) in 2016, of which CHF 2.1 billioniii (US$2.1 billion) was in
Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease15.12.2017 12:34 | Pressemelding
Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (Euronext Brussels and NASDAQ: TIG) (“TiGenix”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), in conjunction with the Committee for Advanced Therapies (CAT), has adopted a positive opinion recommending a marketing authorization (MA) for investigational compound Cx601 (darvadstrocel). Cx601 is expected to be indicated for the treatment of complex perianal fistulas in adult patients with non-active/mildly active luminal Crohn’s disease, when fistulas have shown an inadequate response to at least one conventional or biologic therapy.2 This recommendation marks the first allogeneic stem cell therapy to receive a positive CHMP opinion in Europe. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/201712
Bitcoin Romania and Twispay Announce Integration Partnership Providing Users with the Ability to Purchase Bitcoin with Bank Cards15.12.2017 12:21 | Pressemelding
Bitcoin Romania, leading Eastern European Bitcoin exchange & brokerage firm, and Twispay, Swiss-owned European payment processor and FinTech pioneer, today announced the availability of a payment integration that allows a global clientele to acquire Bitcoin and Ethereum cryptocurrencies using Visa and Mastercard bank cards. Unprecedented in Romania, this is one of the first East-Central European integration partnerships that allow consumers to use their cards to purchase cryptocurrency. Until recently, investors could only acquire cryptocurrencies through bank transfers and cash deposits, but the volatility of cryptocurrency markets dictates the need for additional operational flexibility. Investors require faster, safer, more reliable, and more comfortable ways to complete purchases. “One minute can make the difference between a million lost and a million earned. That is pr
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom